Marcus Schabacker - 09 Oct 2024 Form 4 Insider Report for Enveric Biosciences, Inc. (ENVB)

Reporting relationship: Director
Issuer ticker: ENVB
Reported as of: 09 Oct 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Oct 2024, 19:18:57 UTC
Next SEC filing: 30 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Marcus Schabacker

Key filing fact

Marcus Schabacker filed Form 4 for Enveric Biosciences, Inc. (ENVB) on 11 Oct 2024.

Key facts

This page summarizes Marcus Schabacker's Form 4 filing for Enveric Biosciences, Inc. (ENVB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Oct 2024, 19:18.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENVB transaction

Common Stock

Award

Transaction value: $0
Shares: +47,733
Change %: +14917%
Price: $0.000000
Shares after: 48,053
Date: 09 Oct 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the "Plan"). Such shares shall vest in full on December 31, 2024, subject to the terms and conditions of the Plan and the reporting person's restricted stock award agreement.